Navigation Links
PG500 Series Presented at the AACR Annual Meeting in San Diego
Date:4/13/2008

BRISBANE, Australia, April 14 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL) (Nasdaq: PGLA) announced today that it had presented new data on its patented PG500 series of compounds at the annual American Association for Cancer Research (AACR) meeting being held in San Diego. The meeting brings together approximately 17,000 participants from around the world to discuss new and significant advances in the knowledge surrounding the causes, diagnosis, treatment and prevention of cancer.

The data presented shows that this series of heparan sulfate mimetic compounds have very strong inhibition of angiogenesis and metastasis and strong anti-tumor activity in some aggressive tumor models. The data firmly supports the continued pre-clinical development of this new series of compounds as anti-cancer agents.

PG545 has been chosen as the lead candidate for additional studies required to support an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA). Dr. Anand Gautam, Vice President, Drug Discovery, stated, "PG545 was selected over and above other compounds based on a comprehensive target product profile incorporating aspects such as efficacy, pharmacokinetics, toxicology and ease of manufacture."

Depending upon the outcome of these further studies we expect to submit an IND application with the US-FDA late this calendar year, or early 2009.

About Progen: Progen Pharmaceuticals is a globally focused biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has operations in Australia and the US.

About the PG500 series: Progen has an innovative small molec
'/>"/>

SOURCE Progen Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. BioVascular Inc. Closes $10.87 Million Series C Financing
2. Globus Medical Raises $110 Million in Series E Financing Round
3. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
4. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
5. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
10. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
11. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... MEETING, Pa., Nov. 20 ...hat questions why currently available medications ...ng ignored, ECRI Institute, an independent nonprof...ence on Finasteride for Prevention of Prostate Ca...2009, New York Times article, " Drugs to Deter S...
(Date:11/19/2009)...land, Nov. 19 Warner Chilcott plc ...s previously announced secondary offering of 20,00...lic of $22.25 per share. The selling shareholders...rs, DLJ Merchant Banking, J.P. Morgan Partners (ad... L.P., certain other institutional investors and m...
(Date:11/19/2009)...N, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm...al ingredients (APIs), announced that its,Tainan f...rtification from,SafeBridge(R) Consultants, Inc. T...and proficiency in the safe handling of potent act... to specific laboratories and,production areas use...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Timing of Oxygen After a Stroke May Matter 59768 1Timing of Oxygen After a Stroke May Matter 59768 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 1PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 3Mercury Levels Not Abnormal in Autistic Children 59764 1Mercury Levels Not Abnormal in Autistic Children 59764 2Mercury Levels Not Abnormal in Autistic Children 59764 3
(Date:11/20/2009)..., Nov. 20 Rates of infec...ked in late October, but the pandemic flu virus co... age groups, including the elderly, according to a...E: DGX ), the world,s leading provider of diagno...its most recent Quest Diagnostics Health Trends(TM...
(Date:11/20/2009)...0 The following is a st...e Nevada Health Care Association: ,, "The Nevad...ks Senate Majority Leader Harry Reid for his leade...r goal of protecting every Nevada seniors, ongoing...ng the strength and viability of our state,s vital...
(Date:11/20/2009)...ember 20, 2009Emergency medical service (EMS) prov...,000 cardiac arrests each year. Only 5 to 10 perc...ve. Better quality cardiopulmonary resuscitation ... associated with better patient outcome. The Resu... clinical research network to study prehospital tr...
(Date:11/20/2009)...igh and is expected to continue, CDC says, , ...reas of the United States are seeing declines in H...said Friday, and while the disease remains widespr...eported last week. , "We are beginning to see s...try, but there is still a lot of influenza everywh...
(Date:11/20/2009)...ANGELES, Nov. 20 California minori...can Families, The Wall/Las Memorias, Latina Breast...rogram, and the Real Medicine Foundation today sen... the company to reconsider harmful and discriminat...ield specifically calls for an end to the practice...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
...ted; Health Concerns Include Possible ...Nov. 2 In what is being described,as one of the w...ry,officials with the United Nations Children,s Fu...f particular concern to UNICEF and the Mexican Min...
... Optometrists in Vision,Development (COVD) ( http:...bacher, O.D., FCOVD, was installed as its 29th pre...ization,s 37th Annual Meeting held on,October 20. ...cceeds Dr. Drusilla Grant, O.D., FCOVD, as COVD,s ...
...tCall/ - The Westaim Corporation,announced today t...tion,for a credit line of $12.6 million from a maj... be available for one year and will be secured by ...,September, the Company realized proceeds of $2.8 ...
...T, Inc.,(Nasdaq: XTNT ) today reported financial ...2007. The company reported a net loss of $9.5 mil...2007, compared to a net loss of $8.0 million, or,$...standing of 22.7 million as compared to 2.8 millio...
...aise One Million Inches of Hair to Help ...CINNATI, Nov. 2 Two-time Oscar winner,Hilary Swan...powerful,declaration of support for women with can... have lost their hair due to,cancer treatment. "A...
...future, national litigation., BOSTON, Nov. 2 Tod...illions of dollars in damages against drug giants,...(NYSE: BMY ) for the,companies, role in unfair tr...dge Patti Saris ruled that AstraZeneca and,Bristol...
Other Medicine News:Health News:UNICEF Readies to Assist Mexican Flood Victims 2Health News:UNICEF Readies to Assist Mexican Flood Victims 3Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 2Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 3Health News:The Westaim Corporation update on status of short-term investments 2Health News:XTENT Announces Third Quarter 2007 Financial Results 2Health News:XTENT Announces Third Quarter 2007 Financial Results 3Health News:XTENT Announces Third Quarter 2007 Financial Results 4Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 2Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 3Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 4Health News:Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case 2Health News:Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case 3
Sysmex CA-7000 Automated Coagulation Analyzer
Sysmex CA-1500 Automated Coagulation Analyzer
auto-Lancet™
...ng your blood glucose regularly, you want the proc... spring-loaded lancet systems often penetrate too ...painful dilation or tearing of skin tissue. The AC...ar action that provides greater comfort. It will b...
Medicine Products: